{{Short description|American neuromodulation company}} {{Infobox company | name = Neuronetics, Inc. | logo = File:Neuronetics logo-RGB purple.jpg | logo_size = | type = Public | traded_as = {{NASDAQ|STIM}}<br />Russell 2000 Index component | key_people = Keith J. Sullivan<br /><small>(President and CEO)</small><ref name="Sullivan">{{cite press release |url=http://ir.neuronetics.com/news-releases/news-release-details/neuronetics-announces-appointment-keith-j-sullivan-president-and |title=Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer. |publisher=Neuronetics |accessdate=July 15, 2020}}</ref><ref>{{cite web |url=https://seekingalpha.com/news/3591173-neuronetics-names-new-ceo |title=Neuronetics names new CEO. |publisher=Seeking Alpha |accessdate=July 15, 2020}}</ref><br /> Stephen Furlong <small>(CFO)</small><ref name="Sullivan" /> Andrew Macan<br /><small>(General counsel)</small><ref name="Sullivan" /><br /> <ref>{{cite web |title=NeuroStar Executive Team |url=https://neurostar.com/neuronetics/team/ |publisher=Neuronetics}}</ref> | num_employees = 167<br />{{As of|2018|3|31|df=US}}<ref name=emp>{{cite web |title=Neuronetics, Inc. (stim) IPO |url=https://www.nasdaq.com/markets/ipos/company/neuronetics-inc-403507-87023 |website=NASDAQ.com |language=en-us}}</ref> | founded = 2003 | location = Malvern, PA, United States | website = {{URL|https://neurostar.com/}} }}
'''Neuronetics''' is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003,<ref name=emp/> that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration (FDA) approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device (FDA approval K061053)."<ref>{{Cite journal|title=The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression |date=July 12, 2010|pmc= 3159591 |last1= Horvath |first1= J. C. |last2= Mathews |first2= J. |last3= Demitrack |first3= M. A. |last4= Pascual-Leone |first4= A. |journal= Journal of Visualized Experiments |issue= 45 |page= 2345 |doi= 10.3791/2345 |pmid= 21189465 }}</ref>
They manufacture a transcranial magnetic stimulation device, NeuroStar.<ref>{{Cite web|title=Hello Health: How transcranial magnetic stimulation treats major depressive disorder|url= https://who13.com/hello-iowa/hello-health-how-transcranial-magnetic-stimulation-treats-major-depressive-disorder-2/ |date=November 11, 2020}}</ref> The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.<ref>{{Cite web|title=MercyOne TMS Therapy Des Moines, Iowa| website=YouTube |url= https://www.youtube.com/watch?v=PznTZkcoXDg |date=May 25, 2021}}{{cbignore}}{{Dead YouTube link|date=February 2022}}</ref><ref>{{Cite web|title=Neuronetics' NeuroStar TMS device |url=https://primebehavioralhealth.com/wp-content/uploads/2018/10/Doctor-Patient-Neuron-bckgrnd-1024x528.jpg}}</ref>
==References== {{reflist}}
==External links== * [http://www.neurostar.com NeuroStar.com: Neuronetics website]
{{Authority control}}
Category:2003 establishments in Pennsylvania Category:American companies established in 2003 Category:Companies based in Chester County, Pennsylvania Category:Health care companies based in Pennsylvania Category:Health care companies established in 2003 Category:Manufacturing companies based in Pennsylvania Category:Manufacturing companies established in 2003 Category:Medical technology companies of the United States Category:Neurotechnology Category:Physical psychiatric treatments Category:Privately held companies based in Pennsylvania Category:Treatment of depression